BlackRock’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,307
| Closed | -$11.9K | – | 5418 |
|
|
2024
Q1 | $11.9K | Sell |
1,307
-1
| -0.1% | -$6 | ﹤0.01% | 5070 |
|
|
2023
Q4 | $7.51K | Hold |
1,308
| – | – | ﹤0.01% | 5167 |
|
|
2023
Q3 | $10.3K | Hold |
1,308
| – | – | ﹤0.01% | 5197 |
|
|
2023
Q2 | $69.7K | Hold |
1,308
| – | – | ﹤0.01% | 5011 |
|
|
2023
Q1 | $86.6K | Hold |
1,308
| – | – | ﹤0.01% | 4991 |
|
|
2022
Q4 | $52.4K | Hold |
1,308
| – | – | ﹤0.01% | 5218 |
|
|
2022
Q3 | $94K | Hold |
1,308
| – | – | ﹤0.01% | 5194 |
|
|
2022
Q2 | $71K | Sell |
1,308
-443
| -25% | -$31.3K | ﹤0.01% | 5337 |
|
|
2022
Q1 | $223K | Sell |
1,751
-21
| -1% | -$2.17K | ﹤0.01% | 5085 |
|
|
2021
Q4 | $209K | Buy |
1,772
+12
| +0.7% | +$1.58K | ﹤0.01% | 5099 |
|
|
2021
Q3 | $253K | Buy |
1,760
+41
| +2% | +$6.89K | ﹤0.01% | 4930 |
|
|
2021
Q2 | $351K | Buy |
1,719
+148
| +9% | +$32.9K | ﹤0.01% | 4778 |
|
|
2021
Q1 | $473K | Hold |
1,571
| – | – | ﹤0.01% | 4617 |
|
|
2020
Q4 | $218K | Hold |
1,571
| – | – | ﹤0.01% | 4470 |
|
|
2020
Q3 | $293K | Hold |
1,571
| – | – | ﹤0.01% | 4344 |
|
|
2020
Q2 | $236K | Hold |
1,571
| – | – | ﹤0.01% | 4343 |
|
|
2020
Q1 | $142K | Hold |
1,571
| – | – | ﹤0.01% | 4289 |
|
|
2019
Q4 | $259K | Buy |
1,571
+1,555
| +9,719% | +$494K | ﹤0.01% | 4286 |
|
|
2019
Q3 | $7K | Hold |
16
| – | – | ﹤0.01% | 4759 |
|
|
2019
Q2 | $14K | Hold |
16
| – | – | ﹤0.01% | 4731 |
|
|
2019
Q1 | $17K | Hold |
16
| – | – | ﹤0.01% | 4625 |
|
|
2018
Q4 | $12K | Hold |
16
| – | – | ﹤0.01% | 4646 |
|
|
2018
Q3 | $21K | Hold |
16
| – | – | ﹤0.01% | 4654 |
|
|
2018
Q2 | $21K | Hold |
16
| – | – | ﹤0.01% | 4673 |
|
|
2018
Q1 | $30K | Hold |
16
| – | – | ﹤0.01% | 4513 |
|
|
2017
Q4 | $27K | Hold |
16
| – | – | ﹤0.01% | 4520 |
|
|
2017
Q3 | $49K | Hold |
16
| – | – | ﹤0.01% | 4481 |
|
|
2017
Q2 | $78K | Sell |
16
-1
| -6% | -$4.68K | ﹤0.01% | 4447 |
|
|
2017
Q1 | $59K | Buy |
+17
| New | +$60.2K | ﹤0.01% | 4439 |
|
BlackRock's YTEN Position: Q2 2024 in Review
BlackRock sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 1,307 shares — an estimated $11.9K sold.
BlackRock first reported a position in YTEN in Q1 2017 and held it in 29 quarters. The position peaked at $473K in Q1 2021. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- BlackRock reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- BlackRock sold 1,307 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $11.9K.
- BlackRock first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2017 and held it in 29 quarters.
- BlackRock's Yield10 Bioscience, Inc. Common Stock position peaked at $473K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.